NAD (NAD+)

If you take a supplement to raise this molecule, or you are thinking about starting one, a single question matters before anything else: is the number in your blood actually changing? This test gives you a direct read on that.

It also sits at the center of a genuinely surprising finding. In laboratory and animal work, low levels track with aging, yet in one large human study, people with the highest blood levels had more metabolic disease, not less.

What This Molecule Actually Does

NAD+ (nicotinamide adenine dinucleotide) is a small molecule present in essentially every cell. Its most basic job is to carry electrons during the reactions that convert food into energy, which is why it is described as central to your metabolism. Without it, cells cannot sustainably produce the energy currency (called ATP) that keeps them running.

Beyond energy, this molecule is used up by a set of enzymes that repair damaged DNA, adjust which genes are active, and manage cellular stress and inflammation (families known as sirtuins, PARPs, and CD38). So its abundance reflects both how much energy your cells are handling and how much repair and stress-signaling work they are doing.

Most cells make their own supply through recycling and building pathways, with the liver especially able to build it from scratch using dietary sources. One important caveat shapes everything below: the levels inside your organs are split into separate pools in different parts of the cell, so a whole-blood reading is only a partial window into what is happening in your tissues.

A Research Marker, Not a Settled Test

This is an emerging, exploratory measurement rather than an established clinical test. There are no standardized cutpoints for what counts as high or low, and published measurements vary substantially between laboratories and methods, which means a single number should not drive a health decision on its own.

That uncertainty is exactly why getting a baseline now is useful. You build your own data to compare against over time, and you will be ahead of the curve as the science matures. Treat the result as a trend to follow, not a verdict to act on in isolation.

The Metabolic Disease Surprise

The largest direct human study of measured blood levels was a cross-sectional snapshot of about 1,400 adults in a community setting. People in the highest quarter of blood NAD+ were roughly three times as likely to have metabolic disease as those in the lowest quarter (odds ratio 3.01), and the link held after accounting for standard factors.

The pattern got stronger as metabolic problems stacked up. Compared with the lowest quarter, the highest quarter was about four times as likely to carry three to six metabolic components (odds ratio 4.30), and the risk started climbing around 31 micromoles per liter (a unit for very small concentrations in blood). The association did not differ meaningfully by age or sex. Because this was a single snapshot in time, it cannot tell us whether higher blood levels cause metabolic problems or simply accompany them.

Here is how to hold that finding alongside the aging story, so it does not read as a contradiction. This is not a simple "higher is good, lower is bad" marker. It is a phenotype indicator, meaning it reflects a metabolic state rather than a score to push in one direction, and blood levels do not cleanly mirror the levels inside your tissues. Low tissue levels can accompany aging and disease, while a high whole-blood reading can accompany metabolic dysfunction, because the two measurements are capturing different things.

How Levels Change With Age

In humans, the circulating pool of this molecule and its related metabolites (the smaller molecules it breaks down into and is built from) tends to drift down with age. That decline is real, but its size varies widely depending on which tissue and which specific metabolite you measure, and it is not consistent across every person. Some tissue studies show steep drops, while blood measurements tend to be more modest and mixed.

The practical takeaway is restraint. A single below-average reading does not diagnose "biological aging," and the age-related trend in blood is variable enough that your own trajectory over time will tell you more than one snapshot ever could.

Where Depletion Shows Up in Disease

Much of the disease evidence comes from tissue rather than blood. In Parkinson's disease, muscle and brain measurements of this molecule were lower than in healthy people, and in alcohol-related liver disease, liver tissue showed markedly reduced levels that tracked with disease severity. These are tissue-level findings, not whole-blood results, so they describe the underlying biology more than what your blood test directly reports.

The clearest link between low blood levels and treatment benefit comes from mitochondrial myopathy, a rare disorder of the cells' energy-producing machinery in muscle. There, both blood and muscle levels were low, and the size of the deficit predicted how much patients improved with vitamin B3 therapy. This is the kind of narrow, deficit-driven situation where measuring the molecule has the most established value today.

Why One Reading Is Not Enough

Two things make serial tracking more valuable than any single result. First, laboratory measurements of this molecule vary widely across methods and handling, so one number carries real noise. Second, blood levels shift with diet, supplements, and daily physiology, so a trend line filters out that variation in a way a lone reading cannot.

Retesting is genuinely informative here because the common supplements do move this exact number. Nicotinamide riboside and nicotinamide mononucleotide reliably raise whole-blood NAD+, so a follow-up test can confirm whether your regimen is changing the measurement rather than just your spending.

A reasonable rhythm: get a baseline, retest in three to six months if you are supplementing or making changes, then at least once a year. What you are watching for is your own direction of travel and whether an intervention actually shifts the number.

Making Sense of an Unexpected Result

Because there are no validated thresholds, interpret this number by pattern, not by a line to cross. If your reading comes back high, do not assume it is protective. Given the human data linking higher blood levels to metabolic disease, the sensible next move is to look at the metabolic picture around it: fasting glucose, HbA1c (a three-month average of blood sugar), fasting insulin, a lipid panel, and waist measurement.

If your reading is low and you are trying to raise it with a supplement, the useful step is a repeat test after several weeks on a stable dose to see whether the number responds. For any result that seems inconsistent with the rest of your labs, a clinician who understands that this is an unsettled research marker can help place it in context rather than overreacting to a single value.

When a Single Reading Can Mislead

• Lab-to-lab variability: measurements of this molecule differ substantially across methods and handling, so results are not always comparable between labs or over time unless conditions are consistent.
• Recent supplement doses: nicotinamide riboside and nicotinamide mononucleotide can raise whole-blood levels within days, so a result taken soon after a dose reflects the supplement, not your untreated baseline.
• Sample handling: this molecule is fragile, so delays or improper processing of the blood sample can distort the reading.
• Blood versus tissue: a normal or high blood value does not rule out altered levels inside muscle, liver, or brain, because those pools are measured separately and do not always move together.